“Test, don’t guess and stress.”
It’s a phrase we say often, and today’s episode, we are putting the phrase to the test.
Join us in taking a deep dive into the powerful testing capabilities of RGCC International [1] and how they are reshaping personalized cancer care. From identifying circulating tumor cells to mapping out which therapies (both conventional and natural) may be most effective, their tests can provide actionable, individualized insight so that you and your BCC Coach [2] can make a solid plan of action.
Our guest, Dr. Terri Beim, has spent over a decade working directly with RGCC’s tests and technologies and is dedicated to educating medical professionals on how to use these tools to support real patients in real time.
Now, you get to hear directly from her on how their liquid biopsy tests and other innovative technologies can help guide you and your BCC Coach [2] into turning your results into a clear, data-driven healing plan that can be monitored every step of the way.
Because the more you know, the more effectively you can heal.
____________________________
Where the Full Audio Version can be found:
iTunes [3]
iHeart Radio [4]
Spotify [5]
And, if you haven’t already done so, please SUBSCRIBE & give us a REVIEW!
_____________________________
Here are some highlights from this Podcast:
- Dr. Terri explains how RGCC testing helps “look under the hood” of cancer. To better understand how it behaves and what therapies may be most effective.
- Learn how personalized cancer testing can support every stage of the healing journey, from prevention and active treatment to recurrence prevention.
- Discover the difference between RGCC’s various tests which include the Oncotrace and Onconomics Plus. How they provide detailed insight into tumor behavior and treatment options.
- Dr. Terri shares how RGCC testing can work alongside integrative and conventional cancer care. Helps patients and practitioners make more informed decisions.
- The conversation dives into RGCC’s research-backed approach, advanced therapies, and global presence. Highlighting why personalized medicine continues to grow in the world of integrative oncology.